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1. Introduction 
Cystic fibrosis (CF)is the most common autosomal 
recessive genetic disease in people of Caucasian 
descent. It affects about 1 in 2000 live-born children 
and the frequency of carriers, i.e., CF-heterozygotes, 
has been estimated to be about 1 in 20 in the general 
population [11. Affected children suffer from chronic 
pulmonary obstruction, variable degrees of exocrine 
pancreatic dysfunction and increased levels of sweat 
electrolytes [Z]. The sweat est [3] is so far the only 
generally accepted tool for the laboratory diagnosis 
of cystic fibrosis: it presupposes, however, the pres- 
ence of the patient in the laboratory, is cumbersome 
and only reliable if handled by very experienced 
technicians [4]. Neonatal identification of CF-patients 
through new-born screening, which would allow one 
to apply early therapy and to possibly improve the 
prognosis of pulmonary obstruction has been tried 
[S] with limited success and, therefore, has been 
partly abandoned. Approaches to prenatal diagnosis 
of cystic fibrosis with amniotic fluid have been 
proposed, but so far remained in a purely experi- 
mental stage [6-81. Not only have reliabie diagnostic 
tools been lacking, but the basic metabolic defect of 
this most important genetic disease remained itself 
elusive [21. 
We could, previously, demonstrate hat the genetic 
defect of cystic fibrosis affects the lysosomal system 
[6], and that it leads to a multiple leakage of lyso- 
somal hydrolases Into the extracellular space with a 
concomitant multiple partial intracellular deficiency 
of the co~espon~ng hydrolases 191. To explain 
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these observations we formulated the hypothesis 
that the basic genetic defect in cystic fibrosis affects 
enzyme recognition markers on lysosomal hydrolases 
[9-l l] which serve to anchor these hydrolases onto 
specific lysosomal membrane receptors [121. These 
enzyme recognition markers are thought o be phos- 
phorylated oligosaccharides [ 131 fured onto the 
enzymatic proteins by a secondary processing during 
their passage through the cavities of the endoplasmic 
retic~um. 
If lys&omal enzymes carry abno~~ recognition 
markers, it was reasonable to test if the altered 
enzymatic glycoproteins would display abnormal 
thermostabilities. 
Now we wish to demonstrate hat an abnormal 
thermostability has, indeed, been found in crude 
extracellular fluids for ar-mannosidase, thefirst of 
the ‘leaky’ [9] enzymes analyzed. More extensive 
studies involving several of the ‘leaky’ hydrolases are 
under way and they indicate that the observed 
thermolab~ties can be exploited to develop the 
urgently needed simple diagnostic tools for cystic 
fibrosis. 
2. Materials 
Growth medium: HAM FlO (GIBCO), supple- 
mented with 15% FCS (GIBCO). Coming tissue 
culture flasks: 75 cm2. 4.Methylumbelliferyla-D- 
mannopyranoside (Koch-tight Laboratories, 
Colnbrook, Bucks, U.K.). Spectrophotofluorimeter 
Fe&in-Elmer MPF-4 (Perkin Elmer Ltd., Beaconsfield, 
Buc~~~~e, U.K.). 
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3. Methods 
Fibroblast cell cultures were established in conven- 
tional ways from skin biopsies of normal controls, 
CF-patients and CF-heterozygotes (carriers), and kept 
for three days at 37°C in growth medium in con- 
fluency. After washing, the growth medium was 
replaced for two days with collection medium (2.2 ml 
HAM Fl 0, supplemented with 5% FCS which had 
been previously heat-inactivated for 3 h at S&J). 
The collection medium was then cleared by 2 min 
centrifugation at 5000 X g. Aliquots of this medium 
were distributed into Eppendorf polypropylene tubes 
(1.5 ml, without cover), frozen and stored in liquid 
nitrogen until experimental use. Thawed aliquots 
must be immediately used and can not be refrozen. 
Venous blood was drawn into plastic tubes con- 
taining 25 I.U. heparin Roche per ml blood, put into 
ice water and processed as soon as possible, but at 
the latest in one hour. The blood tubes were first 
centrifuged for 5 min at 400 X g and subsequently 
for 10 min at 3000 X gin a refrigerated swing-out 
centrifuge. Plasma liquots were then distributed 
into Eppendorf tubes, frozen in liquid nitrogen and 
processed as described for collection medium. 
A new technique has been developed for the 
sequential heat inactivation and enzyme assay of very 
small samples of collection medium or of plasma in 
disposable Eppendorf tubes. The important point is 
to protect the small incubation volumes against 
evaporation by covering them with non-fluorescent 
Uvasol paraffin oil (Merck). After each pipetting, the 
oil is forced to cover the upper surface of the incuba- 
tion sample by centrifugation of the incubation vessel 
(Eppendorf propylene tube) in the Runne-Zentrifuge 
(model 104-A, Heidelberg). 
Collection media or plasma were thawed in ambient 
air and kept in ice-water until heat inactivation. To 
10 ~1 of plasma (prediluted 1 : 10 with 0.9% NaCl) or 
collection medium in Eppendorf tubes were added 
25 ~1 of Uvasol oil. Samples were centrifuged 20 set 
at 6000 X g, heated for O-240 min at 41’C in a 
water-bath, and placed 5 min on ice. 10 ~1 of 10 mM 
4-methylumbelliferyl-cll-D-mannopyranoside were 
added, samples centrifuged as above, and incubated 
at 30°C for 90 or 180 min, respectively. Reactions 
were stopped by placing tubes in ice-water for 5 min. 
1 ml of 0.5 M carbonate buffer (pH 10.7) was added 
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flattens off and behaves like the normal control 
during the second part of heat inactivation, Extra- 
polation of the last 2 h CF-heterozygote values to 
zero time seems to indicate that culture media and 
plasma from heterozygotes are composed of two 
different ypes of ar-mannosidase molecules: about 
50% of the molecules eem to be thermolabile (as in 
the CF-homozygote), about 50% thermostable (as in 
the normal control). As will be discussed, this observa- 
tion must, however, be interpreted with great caution. 
A mixture of equivalent amounts of cell culture 
medium from a normal control with that from a 
CF-homozygote resulted in heat-inactivation kinetics 
which were almost identical to the one described for 
the medium of CF-heterozygotes (data not shown). 
The heat-inactivation curve of CF-homozygotes in
blood plasma, as compared to the one in culture 
medium, seems to flatten off slightly during the last 
hour of inactivation. This might indicate the presence 
of relatively higher levels of ‘residual thermostable’ 
a-mannosidase in blood plasma s compared to cell 
culture medium. 
4. Results 
Figure 1 a displays heat-inactivation curves of 
human cu-mannosidase in tibroblast culture medium 
from one normal individual, one obligate CF- 
heterozygote and one CF-homozygote, xposed for 
various lengths of time to 41°C and assayed at pH 5.4. 
Figure 1 b displays heat-inactivation curves of 
human o-mannosidase in blood plasma of one normal 
individual, one obligate CF-heterozygote and one CF- 
homozygote, exposed for various lengths of time to 
41°C! and assayed at pH 5.4. Different indi~du~s 
have been used for heat-inactivation studies with cell 
culture medium and blood plasma, respectively. 
For corresponding genotypes the kinetics of heat 
inactivation of a-mannosidase at 41*C seems to be 
almost identical in culture medium or blood plasma. 
While the normal control shows hardly any loss of 
activity, the CFheterozygote as well as the CF- 
homozygote are inactivated to about the same degree 
during the first 40 min of incubation; thereafter the 
heat-inactivation curve of CF-heterozygotes rapidly 
enzymes [9--l 11. The fact that abnormal thermo- 
labilities are observable as well in culture media as in 
Volume 104, number 2 FEBS LETTERS August 1919 
plasma of CF-patients and carriers underlines that we 
are not dealing with a cell culture artefact. 
In order to define the molecular .defect in cystic 
fibrosis, it will be necessary to study if the observed 
‘thermolability’ isdue to the action of proteinases, or
if it is due to abnormally stable inhibitors, or if the 
a-mannosidase will remain thermolabile in the puri- 
Aed stage. At present, we can only speculate on why 
the inactivation of the o-marmosidase fraction in CF- 
homo~gotes is not considerably faster than observed. 
To exploit the present observations for the 
development of diabolic took, it will have to 
be shown that the apparent thermolab~ity of
cu-mannosidase or other lysosomal hydrolases in 
crude extracellular fluids is a general characteristic 
of CF-patients and carriers. We are presently studying 
heat inactivation kinetics of a large number of con- 
trols, carriers and CF-patients, in culture medium as 
well as in blood plasma. The results of this study 
have, so far, been very encouraging and follow the 
expected pattern, 
It seems, therefore, likely that based on present 
observations simple methods will be developed which 
-C. - - -. 
0 4tl so ml loll roe No 
minutes 
allow one to carry out post- and prenatdl diagnosis, 
neonatal screening and carrier detection in cystic 
fibrosis. 
5. Discussion 
Three technical points must be strictly followed in 
order to successfully repeat he present study. 
First, blood plasma nd collection media must be 
rapidly prepared and processed ~me~ately~ Some of 
the hydrolases tudied seem to be ~e~olab~e, even 
in normal individuals, and plasma or media aliquots 
can, therefore, not be repeatedly thawed and frozen. 
Second, evaporation of the small incubation 
volumes must be avoided by covering with non 
fluorescent oil in order to detect he real kinetics of 
heat-inactivation. 
Third, blood plasma instead of serum must be used. 
During coagulation on-leaky thermostable hydrolases 
are released from ~rombocytes; the level of thermo- 
stable hydrolases i , therefore, increased in serum as 
compared to plasma nd distorts the thermo- 
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The px~~ousabservationthatseverall~~~~~m~ 
hy~ol~ses leak into the medium of cell cultures from 
CF-pat~e~ts and CF-hetero~gotes [9f* and the present 
de~o~tration that at least one of these ‘leaky’ 
e~~~es - ~-~a~~o~da~ - is ab~o~~~ thermo- 
labile in crude extxacelhdar fluids, supports the 
theory that the genetic defect of cystic fibrosis leads 
to abnormal recognition markers on lysosomal 
and smples centrifuged as above. ~u~~eace~~ 
was performed with the s~ectro~~o~eta~~ 
excitation wave length 360, emission 448, 
Professor A. Hennequet, Hapital N~c~e~~~~f~ts 
Malades (Paris), has kindly allowed us td collect 
plasma samples from his CF-patients and obligate 
beterozy~otes. We wottld like to thank Dw M. ~ldbe~~ 
~~t~tut Pasteur) for vduabfe ~sc~~~ns. ‘&is study 
has been supported grant I.N.S.E.R.M. Nr 36.76.68, 
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